Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 6/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 6/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 6/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 6/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 6/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | ACLY | P53396 | 1/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | GOT1 | P17174 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16711570 | 0.83 | GABRG2 (0.43) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL23499270 | 0.79 | CASP6 (0.40) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL2836367 | 0.79 | ACLY (0.39) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL2836445 | 0.79 | ACLY (0.39) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL13911004 | 0.78 | GOT1 (0.42) | NPY5RCYP11B2CASP6HDAC4P2RX7 | |
| SCHEMBL27963820 | 0.78 | NPY5R (0.40) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL27930092 | 0.75 | KDM4E (0.54) | GRM5 | |
| SCHEMBL1456807 | 0.72 | GOT1 (0.46) | NPY5RCYP11B2CASP6HDAC4P2RX7 | |
| SCHEMBL30792004 | 0.72 | GOT1 (0.46) | NPY5RCYP11B2CASP6HDAC4P2RX7 | |
| SCHEMBL29442588 | 0.72 | GOT1 (0.46) | NPY5RCYP11B2CASP6HDAC4P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4232440-A1 | ZEALACTONE DERIVATIVES AS PLANT GROWTH REGULATORS | Syngenta Crop Protection AG (CH) | 2023-08-30 | — | — | EP | disclosed |
| WO-2022084346-A1 | ZEALACTONE DERIVATIVES AS PLANT GROWTH REGULATORS | SYNGENTA CROP PROTECTION AG (CH) | 2022-04-28 | — | — | WO | disclosed |
| EP-3965573-A1 | HIGH SPREADING AND UPTAKE ULV FORMULATIONS | Bayer Aktiengesellschaft (DE) | 2022-03-16 | — | — | EP | disclosed |
| EP-3965571-A1 | HIGH SPREADING ULV FORMULATIONS FOR FUNGICIDES | Bayer Aktiengesellschaft (DE) | 2022-03-16 | — | — | EP | disclosed |
| EP-3810762-A1 | PLANTS CONTAINING ELITE EVENT EE-GM5 AND METHODS AND KITS FOR IDENTIFYING SUCH EVENT IN BIOLOGICAL SAMPLES, AND TREATMENT THEREOF | BASF Agricultural Solutions Seed US LLC (US) | 2021-04-28 | — | — | EP | disclosed |
| WO-2020225436-A1 | HIGH SPREADING, UPTAKE AND RAINFASTNESS ULV FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-11-12 | — | — | WO | disclosed |
| WO-2020225435-A1 | HIGH SPREADING AND UPTAKE ULV FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-11-12 | — | — | WO | disclosed |
| WO-2020225439-A1 | ULV FORMULATIONS WITH ENHANCED RAINFASTNESS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-11-12 | — | — | WO | disclosed |
| WO-2020225431-A1 | HIGH SPREADING ULV FORMULATIONS FOR FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-11-12 | — | — | WO | disclosed |
| CN-108290886-B | 2- (hetero) aryl-substituted fused bicyclic heterocyclic derivatives as pest control agents | 拜耳作物科学股份公司 | 2020-11-03 | — | — | CN | disclosed |
| CN-110506040-A | Kill the oxadiazole derivatives of microorganism | SYNGENTA PARTICIPATIONS AG | 2019-11-26 | — | — | CN | disclosed |
| CN-110392683-A | Kill the oxadiazole derivatives of microorganism | 先正达参股股份有限公司 | 2019-10-29 | — | — | CN | disclosed |
| CN-110382492-A | Microbicidal oxadiazole derivatives | 先正达参股股份有限公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-109195956-A | Microbicidal oxadiazole derivatives | 先正达参股股份有限公司 | 2019-01-11 | — | — | CN | disclosed |
| US-9062040-B2 | Solid forms of an azocyclic amide | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-06-23 | — | — | US | disclosed |
| US-20140127322-A1 | SOLID FORMS OF AN AZOCYCLIC AMIDE | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-08 | — | — | US | disclosed |
| US-8669277-B2 | Solid forms of an azocyclic amide | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-03-11 | — | — | US | disclosed |
| US-20120034315-A1 | SOLID FORMS OF AN AZOCYCLIC AMIDE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140127322-A1 | SOLID FORMS OF AN AZOCYCLIC AMIDE | NOD1, NUAK1, DDT | GABRA1 3151/4885GABRG2 3475/4885GABRB3 4348/4885 |
| US-20120034315-A1 | SOLID FORMS OF AN AZOCYCLIC AMIDE | NOD1, NUAK1, DDT | GABRA1 3151/4885GABRG2 3475/4885GABRB3 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.